Canada markets close in 2 hours 14 minutes

Alligator Bioscience AB (publ) (7AL.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.0740+0.0033 (+4.67%)
As of 09:17AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 58.10M
Enterprise Value 55.86M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.27
Price/Book (mrq)8.19
Enterprise Value/Revenue 11.72
Enterprise Value/EBITDA -0.09

Trading Information

Stock Price History

Beta (5Y Monthly) 1.34
52-Week Change 355.04%
S&P500 52-Week Change 328.04%
52 Week High 30.1224
52 Week Low 30.0206
50-Day Moving Average 30.0772
200-Day Moving Average 30.0590

Share Statistics

Avg Vol (3 month) 31.48k
Avg Vol (10 day) 3N/A
Shares Outstanding 5758.04M
Implied Shares Outstanding 6821.73M
Float 8414.31M
% Held by Insiders 148.47%
% Held by Institutions 14.50%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in SEK.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-581.61%

Management Effectiveness

Return on Assets (ttm)-108.23%
Return on Equity (ttm)-492.71%

Income Statement

Revenue (ttm)59.25M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)-41.10%
Gross Profit (ttm)N/A
EBITDA -248.24M
Net Income Avi to Common (ttm)-248.59M
Diluted EPS (ttm)-0.0500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)66.12M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)16.1M
Total Debt/Equity (mrq)135.78%
Current Ratio (mrq)0.79
Book Value Per Share (mrq)0.79

Cash Flow Statement

Operating Cash Flow (ttm)-189.28M
Levered Free Cash Flow (ttm)-100.16M